New Chimeric Antigen Receptor Design for Solid Tumors
In recent years, chimeric antigen receptor (CAR) T-cell therapy has become popular in immunotherapy, particularly after its tremendous success in the treatment of lineage-restricted hematologic cancers. However, the application of CAR T-cell therapy for solid tumors has not reached its full potentia...
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Frontiers Media S.A.
2017-12-01
|
| Schriftenreihe: | Frontiers in Immunology |
| Schlagworte: | |
| Online Zugang: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01934/full |